Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Indications -- scarring, fibrosis, adhesions, keloids -- Ignore unavailable to you. Want to Upgrade?

To: nigel bates who wrote (6)	10/7/2003 12:47:15 PM
From: scaram(o)uche	Read Replies (1) \| Respond to of 32

That would be sooooooooooooo cool. Wound healing is an old target of biotech, one of the first. The sector has been shooting blanks for the better part of three decades. Sort of like the common cold..... anything "incremental" would fit the new world's medical economies. I've been ranting for ages about global crowding and the ease of transport, and what it will mean to medicine; we need to get out on the learning curve, we need to get aggressive. For wound healing, one only need look to the insanity that is Iraq, U.S. version. Wounds, a growing market. Burns, wounds.... adults, children........ one hell of a lot of children burned, wounded, maimed, killed. Good for business! Simply up the BioShield budget -- 2007 -- to include those damn bugs that infect wounds. The Department of Defense will take care to make sure that those with wounds receive the very best of medication.